Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Beneficial effects of nonpharmacological interventions in the management of essential hypertension.

Vamvakis A, Gkaliagkousi E, Triantafyllou A, Gavriilaki E, Douma S.

JRSM Cardiovasc Dis. 2017 Jan 1;6:2048004016683891. doi: 10.1177/2048004016683891. Review.

2.

Applying Psychological Theories to Promote Long-Term Maintenance of Health Behaviors.

Joseph RP, Daniel CL, Thind H, Benitez TJ, Pekmezi D.

Am J Lifestyle Med. 2016 Nov;10(6):356-368. doi: 10.1177/1559827614554594.

3.

Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas.

Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, Druss B, Dudek K, Freeman M, Fujii C, Gaebel W, Hegerl U, Levav I, Munk Laursen T, Ma H, Maj M, Elena Medina-Mora M, Nordentoft M, Prabhakaran D, Pratt K, Prince M, Rangaswamy T, Shiers D, Susser E, Thornicroft G, Wahlbeck K, Fekadu Wassie A, Whiteford H, Saxena S.

World Psychiatry. 2017 Feb;16(1):30-40. doi: 10.1002/wps.20384.

4.

7th Brazilian Guideline of Arterial Hypertension: Chapter 11 - Arterial Hypertension in the elderly

Malachias MVB, Ferreira S Filho, Souza WKSB, Ribeiro JM, Miranda RD, Jardim TSV.

Arq Bras Cardiol. 2016 Sep;107(3 Suppl 3):64-66. doi: 10.5935/abc.20160161. English, Portuguese. No abstract available.

5.

7th Brazilian Guideline of Arterial Hypertension: Chapter 5 - Therapeutic Decision and Targets

Malachias MVB, Andrea Araujo Brand√£o AA, Kaiser S, Moreira O Filho.

Arq Bras Cardiol. 2016 Sep;107(3 Suppl 3):25-29. doi: 10.5935/abc.20160155. English, Portuguese. No abstract available.

6.

Change in Oxidative Stress of Normotensive Elderly Subjects Following Lifestyle Modifications.

Bhatnagar A, Tripathi Y, Kumar A.

J Clin Diagn Res. 2016 Sep;10(9):CC09-CC13.

7.

Drug Interactions in Parkinson's Disease: Safety of Pharmacotherapy for Arterial Hypertension.

Bitner A, Zalewski P, Klawe JJ, Newton JL.

Drugs Real World Outcomes. 2015 Mar;2(1):1-12. Review.

8.

Effect of Resistance Training and Caloric Restriction on the Metabolic Syndrome.

Normandin E, Chmelo E, Lyles MF, Marsh AP, Nicklas BJ.

Med Sci Sports Exerc. 2017 Mar;49(3):413-419. doi: 10.1249/MSS.0000000000001122.

PMID:
27741216
9.

Effects of a Health-Partner Intervention on Cardiovascular Risk.

Al Mheid I, Kelli HM, Ko YA, Hammadah M, Ahmed H, Hayek S, Vaccarino V, Ziegler TR, Gibson G, Lampl M, Alexander RW, Brigham K, Martin GS, Quyyumi AA.

J Am Heart Assoc. 2016 Oct 11;5(10). pii: e004217.

10.

Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention.

Cook NR, Appel LJ, Whelton PK.

J Am Coll Cardiol. 2016 Oct 11;68(15):1609-1617. doi: 10.1016/j.jacc.2016.07.745.

PMID:
27712772
11.

The Relationship between Metabolic Syndrome and Osteoporosis: A Review.

Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S.

Nutrients. 2016 Jun 7;8(6). pii: E347. doi: 10.3390/nu8060347. Review.

12.
13.

The impact of continued intervention on weight: Five-year results from the weight loss maintenance trial.

Coughlin JW, Brantley PJ, Champagne CM, Vollmer WM, Stevens VJ, Funk K, Dalcin AT, Jerome GJ, Myers VH, Tyson C, Batch BC, Charleston J, Loria CM, Bauck A, Hollis JF, Svetkey LP, Appel LJ; Weight Loss Maintenance Collaborative Research Group..

Obesity (Silver Spring). 2016 May;24(5):1046-53. doi: 10.1002/oby.21454.

PMID:
26991814
14.

2013 Korean Society of Hypertension guidelines for the management of hypertension: part III-hypertension in special situations.

Shin J, Park JB, Kim KI, Kim JH, Yang DH, Pyun WB, Kim YG, Kim GH, Chae SC; Guideline Committee of the Korean Society of Hypertension..

Clin Hypertens. 2015 Apr 15;21:3. doi: 10.1186/s40885-014-0014-1.

15.
16.

The FAITH Trial: Baseline Characteristics of a Church-based Trial to Improve Blood Pressure Control in Blacks.

Schoenthaler A, Lancaster K, Midberry S, Nulty M, Ige E, Palfrey A, Kumar N, Ogedegbe G.

Ethn Dis. 2015 Aug 7;25(3):337-44. doi: 10.18865/ed.25.3.337.

17.

A virtual reality intervention (Second Life) to improve weight maintenance: Rationale and design for an 18-month randomized trial.

Sullivan DK, Goetz JR, Gibson CA, Mayo MS, Washburn RA, Lee Y, Ptomey LT, Donnelly JE.

Contemp Clin Trials. 2016 Jan;46:77-84. doi: 10.1016/j.cct.2015.11.019.

18.

Lifestyle modification for resistant hypertension: The TRIUMPH randomized clinical trial.

Blumenthal JA, Sherwood A, Smith PJ, Mabe S, Watkins L, Lin PH, Craighead LW, Babyak M, Tyson C, Young K, Ashworth M, Kraus W, Liao L, Hinderliter A.

Am Heart J. 2015 Nov;170(5):986-994.e5. doi: 10.1016/j.ahj.2015.08.006.

19.

Secondary cardiovascular prevention in older adults: an evidence based review.

Damluji AA, Ramireddy A, Otalvaro L, Forman DE.

J Geriatr Cardiol. 2015 Sep;12(5):459-64. doi: 10.11909/j.issn.1671-5411.2015.05.019. No abstract available.

20.

Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective.

Burnier M, Wuerzner G, Bochud M.

Front Physiol. 2015 Aug 13;6:227. doi: 10.3389/fphys.2015.00227. Review.

Supplemental Content

Support Center